Scientists have developed a new scientific tool to predict which individuals are at high risk of developing serious obesity-related complications, including those who are overweight but not yet obese. The tool, named Obscore, aims to complement traditional Body Mass Index (BMI) scores by offering a more accurate and personalised method to identify at-risk individuals for earlier monitoring and interventions.
How Obscore Works
Developed by academics from Queen Mary University of London and the Berlin Institute of Health, Obscore utilised extensive data from 200,000 middle-aged adults in the UK Biobank study. Researchers analysed over 2,000 health factors to identify 20 commonly collected health measures that can predict 18 different obesity-related complications. These measures include blood pressure, cholesterol levels, and blood sugar readings, which are routinely gathered in primary care.
Potential Impact on NHS Resources
The innovation seeks to assist the NHS and other health officials in prioritising individuals who would most benefit from weight-loss interventions, such as new medications, given finite resources. By identifying high-risk individuals earlier, the tool could enable targeted use of weight-loss jabs like Ozempic, potentially preventing the progression to severe obesity and its associated health problems.
Dr. Sarah Clarke, lead researcher at Queen Mary University, stated: “Obscore moves beyond BMI to give a more nuanced risk profile. This means we can offer interventions to those who need them most, before they develop serious complications.” The tool is currently being validated in clinical settings, with hopes for integration into NHS health checks within the next two years.
